Patti L, Romano G, Di Marino L, Annuzzi G, Mancini M, Riccardi G, Rivellese A A
Institute of Internal Medicine and Metabolic Diseases, Second Medical School, University Federico II, Naples, Italy.
Diabetologia. 1993 Feb;36(2):155-60. doi: 10.1007/BF00400698.
Very low density lipoproteins (VLDL) have an abnormal lipid composition in Type 1 (insulin-dependent) diabetic patients. Since VLDL represent a heterogeneous lipoprotein class, this might be due either to a shift in the distribution or to an abnormal composition of VLDL subclasses or both. In order to investigate these possibilities and to evaluate possible pathogenetic mechanisms, lipid composition (non-esterified and esterified cholesterol, triglycerides, phospholipids) of four VLDL subfractions of decreasing size (A: Svedberg flotation unit [Sf] > 400, B: Sf > 400, B: Sf 175-400, C: Sf 100-175, D: Sf 20-100), isolated by density gradient preparative ultracentrifugation, and plasma post-heparin lipolytic activity (lipoprotein lipase and hepatic lipase) were evaluated in 13 male normolipidaemic insulin-dependent diabetic patients in good glycaemic control (HbAlc 6.9 +/- 0.5%) (mean +/- SEM) and 9 male control subjects matched for age, body mass index and plasma lipid values. Compared to control subjects, diabetic patients showed a reduced total lipid concentration of VLDL of intermediate size (B and C) reaching statistical significance only for VLDL C (0.16 +/- 0.02 vs 0.24 +/- 0.03 mmol/l; p < 0.05). Expressing each VLDL subfraction as percent of the total VLDL lipid concentration, a significant decrease in particles of intermediate size (C) (20.5 +/- 1.6 vs 27.9 +/- 1.5%; p < 0.005) was present, which was compensated by an increase in the smallest ones (D) (50.5 +/- 2.7 vs 37.4 +/- 3.1%; p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
在1型(胰岛素依赖型)糖尿病患者中,极低密度脂蛋白(VLDL)具有异常的脂质组成。由于VLDL代表一类异质性脂蛋白,这可能是由于VLDL亚类分布的改变、组成异常或两者兼而有之。为了研究这些可能性并评估可能的发病机制,通过密度梯度制备超速离心法分离出四种大小递减的VLDL亚组分(A:斯维德伯格漂浮单位[Sf]>400,B:Sf 175 - 400,C:Sf 100 - 175,D:Sf 20 - 100),并对其脂质组成(非酯化和酯化胆固醇、甘油三酯、磷脂)以及血浆肝素后脂解活性(脂蛋白脂肪酶和肝脂肪酶)进行了评估,研究对象为13名血糖控制良好(糖化血红蛋白[HbAlc] 6.9±0.5%)(均值±标准误)的男性正常血脂胰岛素依赖型糖尿病患者以及9名年龄、体重指数和血浆脂质值相匹配的男性对照者。与对照者相比,糖尿病患者中等大小(B和C)的VLDL总脂质浓度降低,仅VLDL C达到统计学显著性(0.16±0.02对0.24±0.03 mmol/L;p<0.05)。将每个VLDL亚组分表示为VLDL总脂质浓度的百分比时,中等大小(C)的颗粒显著减少(20.5±1.6对27.9±1.5%;p<0.005),这被最小颗粒(D)的增加所补偿(50.5±2.7对37.4±3.1%;p<0.05)。(摘要截取自250词)